>
pdufa.bio

PMN310

Updated ยทnext FDA decision on the calendar

PMN310 is a ProMIS Neurosciences Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

PMN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: ProMIS Neurosciences Inc. (PMN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026PMN

Questions

When is PMN310's next FDA decision or readout?

The next tracked catalyst for PMN310 is a Readout in Q3 2026.

What happened at PMN310's most recent FDA decision?

No FDA decision for PMN310 is in our archive yet.

Who makes PMN310?

ProMIS Neurosciences Inc. (PMN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.